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PENGEKSPRESAN  mRNA NITRIK OKSID SINTASE TERARUH DALAM  
KELOID MENGGUNAKAN FRAKSI KAYA TOKOTRIENOL DALAM 
KULTUR PRIMER EPIDERMIS KERATINOSIT MANUSIA DAN KULTUR 
PRIMER DERMIS FIBROBLAS MANUSIA  
 
 
ABSTRAK 
 
 Keloid dicirikan oleh pemendapan kolagen yang berlebihan yang boleh 
merosakkan tisu yang sihat. Penggunaan produk berasaskan Vitamin E- tokoferol 
secara meluas serta penggunaan tokotrienol (T3) berpotensi untuk merawat pelbagai 
penyakit kulit. Terdapat kemungkinan bahawa fraksi kaya tokotrienol (TRF) dapat 
mempengaruhi proses penyembuhan luka secara normal,  pembentukan parut timbul 
dan keloid semasa proses keradangan. Walaubagaimanapun, terdapat kekurangan 
bukti saintifik yang mengesahkan keberkesanan terapi TRF dalam pencegahan parut. 
Oleh itu, kajian ini dijalankan untuk menilai kesan-kesan berfaedah TRF dalam 
penyembuhan luka dan rangsangan terhadap ekspresi mRNA nitrik oksid sintase 
teraruh (iNOS) dalam keratinosit kulit dan fibroblas keloid manusia. Kultur primer 
epidermis keratinosit manusia  (pHEK) dan kultur primer dermis fibroblas manusia 
(pHDF) berjaya dihasilkan menggunakan kaedah penceraian sel. Pengesahan pHEK 
dan pHDF dijalankan dengan petanda Cytokeratin-6 (CK6), Involucrin, Heat Shock 
Protein-47 (HSP47) dan protein yang spesifik pada permukaan fibroblas (FSP) 
menggunakan analisis imunositokimia. Kesan TRF pada pHEK dan pHDF 
ditentukan menggunakan cerakin MTT. Pengekspresan mRNA iNOS di dalam hanya 
kultur primer normal dermis fibroblas manusia (pNHDF) dan kultur primer keloid 
dermis fibroblas manusia (pKHDF) yang dirawat dengan TRF di nilai menggunakan 
 xx 
PCR masa sebenar. Kultur primer normal epidermis keratinosit  manusia (pNHEK) 
mencapai kadar pertumbuhan yang lebih tinggi berbanding kultur primer keloid 
epidermis keratinosit  manusia (pKHEK). Sementara itu, pKHDF mempamerkan 
pertumbuhan linear dan mengekalkan pertumbuhan sel pada kadar yang lebih tinggi 
berbanding pNHDF. Kultur pHEK positif bagi kehadiran CK6 dan Involucrin 
manakala HSP47 dan FSP ditemui dalam kultur pHDF. TRF dari 2.85 μg /mL to180 
μg /mL dan TRF (45 μg /mL 180 μg /mL) didapati menghalang pertumbuhan pHEK 
manakala bagi pHDF adalah pada 90 ug /mL pada 72 jam. Pada kepekatan yang 
lebih rendah (2.8-22.5 μg/mL), TRF meningkatkan pertumbuhan sel pHEK pada 24 
dan 48 jam pengeraman tetapi tidak mempunyai kesan yang signifikan dalam jumlah 
sel hidup bagi pHDF pada semua selang masa. Kesan pengurangan dan perencatan 
pertumbuhan pada pHEK dan pHDF mungkin disebabkan oleh kesan perencatan 
proliferasi sel dan kesan antioksidan oleh TRF. Dalam kajian ini, TRF pada 2.8 
μg/mL mengurangkan tahap mRNA iNOS pKHDF seperti dalam pNHDF pada 24 
jam yang mungkin boleh merencatkan penghasilan nitrik oksid (NO) oleh pKHDF. 
Pengurangan tahap mRNA iNOS dalam pKHDF mungkin disebabkan TRF memiliki 
kesan anti oksidan dan anti-fibrogenik. Keputusan ini menunjukkan TRF mungkin 
memainkan  peranan dalam intervensi keloid dengan menekan ekspresi  mRNA 
iNOS. 
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ABSTRACT 
 
Keloid is characterized by excess collagen deposition that can damage 
healthy tissue. With the widespread use of Vitamin E- tocopherols based product and 
the discovery of tocotrienol (T3) potential to treat various skin injuries; there are 
possibilities of tocotrienol-rich fraction (TRF) to intercede normal, hypertrophic, or 
keloid scarring during the inflammatory process. However, there is a lack of 
scientific evidence to validate the efficacy and the therapies of TRF in scar 
prevention. Thus, this study was carried out to evaluate the beneficial effects of TRF 
in wound healing and its possible stimulation towards mRNA expression of inducible 
nitric oxide synthase (iNOS) in keloid human skin keratinocytes and fibroblasts. 
Primary human epidermal keratinocytes (pHEK) and primary human dermal 
fibroblasts (pHDF) were successfully established using cell dissociation method. 
Verification of pHEK and pHDF was conducted using Cytokeratin-6 (CK6), 
Involucrin, Heat Shock Protein-47 (HSP47) and Fibroblast Surface Protein (FSP) 
markers using imunocytochemistry analysis. The effect of TRF on pHEK and pHDF 
were determined by using MTT assay. The mRNA expression of iNOS in primary 
normal human dermal fibroblasts (pNHDF) and primary keloid human dermal 
fibroblasts (pKHDF) treated with TRF was evaluated using real-time PCR. Primary 
normal human epidermal keratinocytes (pNHEK) achieved higher cellular growth 
 xxii 
rate compared to primary keloid human epidermal keratinocytes (pKHEK). Whilst, 
pKHDF exhibited linear growth and sustained higher cellular growth rate compared 
to pNHDF. pHEK cultures were positive for the presence of CK6 and Involucrin 
whereas HSP47 and FSP were found in pHDF cultures. TRF ranged from 2.85 μg/ 
mL to180 μg/ mL. TRF (45 μg/ mL to 180 μg/ mL) was found to inhibit the growth 
of pHEK while for pHDF was at  90 ug/mL at 72 hours. At lower concentrations 
(2.8-22.5 μg/mL), TRF increased pHEK cell growth at 24 and 48 hours of incubation 
but have no significant effect in pHDF viability at all time intervals. TRF at 2.8 
µg/mL has been found to reduce the mRNA expression of iNOS at 24 hours, which 
may in turn suppress the production of nitric oxide (NO) by pKHDF. The observed 
suppression and growth inhibition effect in pHEK and pHDF cultures may be caused 
by the antiproliferative and antioxidant activities of TRF. Whereas, the reduction of 
iNOS mRNA level in pKHDF may suggest that TRF possess antioxidant and 
antifibrogenic effect. This finding showed that TRF may play a role in keloid 
intervention by suppressing the mRNA expression of iNOS. 
 
 
 
 
 
 1 
CHAPTER 1 
 
INTRODUCTION 
 
1.1 Research Background 
 
 The abnormal response to wound healing process may cause the over 
expression of fibroblasts and collagen synthesis.  Overproduction of fibroblasts and 
collagen synthesis will rise above the surrounding skin to form a hypertrophic scar 
(HSc) or continue to extend beyond the site of injury to form a more serious scar 
which is known as keloid.  Keloid and Hypertrophic scar (HSc) have been 
documented to happen in mankind since many years ago. With the development of 
modern technology and the increase in public awareness, efforts have been devoted 
to the better understanding and find effective treatment to control this problem 
globally.  
 Vitamin E has been known to be a major lipid soluble antioxidant in skin, and 
its use has been encouraged by some clinical practitioners for patients with various 
skin abrasions. Vitamin E is believed to have a great potential to accelerate wound 
healing process and improve the cosmetic appearance of scars (Chang et al., 2001). 
In contrast to tocopherols, another Vitamin E isomer (Tocotrienols (T3s)) are poorly 
studied. Only a few studies have shown that T3s exert more significant effect 
compared to tocopherols. Most of tocopherols originate from components of nuts and 
common vegetable oils, whereas T3s are found abundantly in palm oil, oat, barley, 
soybean and rice bran. Palm oil T3s is a complex natural phytonutrient that possess a 
higher antioxidant activity compared to tocopherols. Tocotrienol-Rich Fraction 
(TRF) derived from palm oil containing T3s fraction has been an economical and 
 2 
efficient substitute for alpha tocopherol. TRF may lead to the induction of apoptosis 
in various types of cancer cells, such as breast, colon and hepatoma carcinoma cells. 
Currently, with the extensive used of Vitamin E- tocopherol based product and the 
discovery of potential use of T3s to treat variety skin modalities, TRF may play a 
role to intervene normal, hypertrophic, or keloid scarring by modulating the 
inflammatory response (Sen, 2009). However, there is lack of scientific evidence to 
validate the efficacy and the therapies of TRF in scar prevention. 
 The healing of skin requires enhanced and efficient production of healthy 
collagen for strength and to abbreviate the recovery time without scarring. However, 
the formation of collagen in injured crucial organs needs to be minimized to avoid 
fibrosis and successive loss of organ function. The reduction and the enhancement of 
this collagen formation are likely to have common regulatory mechanisms that 
remain to be explained. Collagen formation can be affected by multiple cellular and 
extracellular factors such as nitric oxide, growth factors and matrix 
metalloproteinases. Recently, studies showed that inducible nitric oxide synthase 
(iNOS) and nitric oxide (NO) play an important role in collagen formation during 
wound healing. Inhibition of NO synthase was found to decreased collagen synthesis 
in wound fibroblasts. Dermal fibroblasts from iNOS-knock out murine fibroblasts 
proliferated more slowly and synthesized less collagen (Schaeffer et al., 1997).  
  Over the years, scar management has proven to be challenging and much 
more left to be learned. According to Sund (2000), about 100 million patients acquire 
scars every year in the developed world.  These statistics resulted from 55 million 
elective surgical procedure and 25 million operations after trauma. Patient with 
significant abnormal scarring may face physical and cosmetic deformities, 
psychological stress and social consequences that might be related to substantial 
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emotional and financial costs. A lot of treatment modalities are carried out to prevent 
this abnormal wound healing but most of the methods are time consuming, expensive 
and sometime not effective. The expression, transcription, and function of the 
inducible isoform iNOS is induced by a variety of cytokines, growth factors and 
inflammatory stimuli on target cells which leads to high NO levels. Therefore, the 
regulation of iNOS occurs mainly at the gene level. Therefore, this study has 
explored the beneficial effects of TRF in wound healing and the possible stimulation 
towards mRNA expression of iNOS in normal and keloid human skin keratinocytes 
and fibroblasts. This fundamental understanding regarding scarring and the 
underlying mechanisms of the potential effect of TRF on wound management will 
have a vast implication on its potential pharmaceutical use. 
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1.1.1 Hypothesis 
 
 TRF is possibly used to inhibit the growth of cells and reduce the expression 
of iNOS mRNA expression in keratinocytes and fibroblasts cultures. 
 
1.1.2 General objectives 
 
The objective of this study is to assess the mRNA expression of iNOS in TRF 
treated primary epidermal human keratinocytes (pHEK) and primary dermal human 
fibroblast (pHDF) cultures from normal and keloid skin tissues. 
 
1.1.3 Specific Objectives 
 
1.1.3.1 To establish pHEK and pHDF culture system from normal skin and keloid 
scars. 
1.1.3.2 To determine the effect of TRF in pHEK and pHDF of normal skin and 
keloid scar. 
1.1.3.3 To verify the expression of iNOS in TRF treated pHDF of normal skin and 
keloid scar. 
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1.2 Literature review 
1.2.1 Skin 
 
 The skin or cutaneous membrane covers the external surface of the body. It 
is the largest organ of the body in surface area and weight. The functions of skin 
include protection of the body against harmful environment and loss of plasma, 
prevention of entry by microorganism, regulation of body temperature and social 
interactive function (Wong and Cheng, 2009). Skin also plays a vital role as a barrier 
against environment and pathogens. Structurally, skin consists of two 
morphologically different layers that are derived from two different germ layers. The 
superficial layer is called epidermis and the deeper and thicker connective tissue 
layer is called dermis (Figure 1). In adults, the skin covers an area of about 2 m
2
 (22 
ft
2
) and weighs 4.5- 5 kg (10-11 lb), about 16% of total body weight. It ranges in 
thickness from 0.5mm (0.02 in) on the eyelids to 4.0 mm (0.16 in) on the heels. 
However, over most of the body it is 1-2 mm (0.04 – 0.08 in) thick. The epidermis 
can vary in thickness depending on the body location, generally about 0.2 mm of 
thickness (Tortora and Grabowski 2003).  
The epidermis is formed by stratified squamous epithelium and does not 
contain blood vessels. It consists of five layers, stratum corneum, lucidium, 
granulosum, spinosum and basale. The epidermis is a highly specialized organ made 
out of keratinocytes and residence melanocytes, Langerhans cells and Merkel cells. 
Dermis is situated between epidermis and subcutaneous fat; consist of network fibers 
of collagen, reticulin and elastin. Like other connective tissues, the dermal layer has 
three separate components, cells, fibers and amorphous ground substance. It supports 
the epidermis structurally and nutritionally (Hunter et al., 1995).  
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Figure 1: Anatomy of human skin. The structure of skin composed of three layers, 
starting with the epidermis, dermis, and hypodermis. The epidermis is primarily 
composed of stratified squamous epithelium of keratinocytes that is divided into four 
layers; stratum corneum (SC), stratum granulosum (SG), stratum spinosum (SS), and 
stratum basale (SB).  Meanwhile, the dermis is primarily composed of fibroblasts 
from mesoderm origin.  Adapted from Wong & Cheng: Skin Tissue Engineering.  
StemBook, ed. The Stem Cell Research Community, StemBook, 
doi/10.3824/stembook.1.44.1, http://www.stembook.org. March 31, 2009. 
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1.2.1.1 Keratinocytes 
 
Keratinocytes are the largest population of epidermal cells in the skin (Figure 
1). They attain their name through their function as warehouses for keratin, the 
protein that provides a physical barrier in the most superficial dead cells of the 
stratum corneum. Keratinocytes are formed through its stem cells located in the 
stratum basal and differentiates within the stratum spinosum (Jablonski, 2004). As 
more cells are produced in the stratum basal, cells above are forced upwards to the 
surface over a period of about 2 months. During transit, keratinocytes can lose some 
synthetic organelles (e.g. rough endoplasmic reticulum and Golgi apparatus). There 
is an elevated production of intracellular tonofilament, keratohyaline, cytoskeleton in 
connecting cytoplasm and desmosomes. Tonofilament and keratohyaline are able to 
combine in forming the matrix and keratin respectively at the level of the stratum 
corneum (Yamamoto and Lizuka, 1998). 
Keratinocytes in stratum spinosum contain lamellar bodies which function to 
store complex carbohydrates, lipids and hydrolytic enzymes. The constituents are 
discharged into the intercellular space in the stratum corneum. They provide a 
complex glycoprotein adhesive between cells. Enzyme phosphatase acid shed in the 
stratum corneum will help to dissolve this attachment and permit shedding of the 
most superficial dead cells. Keratinocytes are also responsible in the production of 
lamellar granules, which perform as a water repellent sealant (Tortora and 
Grabowski, 2003). They are formed continuously in the basal layer and undergo a 
tightly regulated process of differentiation as they progress upwards and become part 
of the cornified epithelium. This maturation process consists essentially of 
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keratinization, but also involves a number of morphological and metabolic events as 
the cells differentiate and lose their nuclei (Cals-Grierson and Ormerod, 2004).  
 
1.2.1.2 Fibroblasts  
 
Fibroblast is the main cells in the dermal layer. Its extracellular matrix (ECM) 
secretions contribute to high tensile strength of the skin (Figure 1). It is involved in 
the formation of granulation tissue. Furthermore, it also play an important role in the 
production of collagen, elastin, fibronectin, sulfated and non-sulfated 
glycosaminoglycans and proteases in wound remodeling (James at al., 2006). 
Fibroblasts have a branched cytoplasm surrounding an elliptical, speckled nucleus 
having one or two nucleoli. Active fibroblasts can be recognized by their abundant 
rough endoplasmic reticulum. Inactive fibroblasts, which are called fibrocytes, are 
smaller and spindle shaped. They have a reduced number of rough endoplasmic 
reticulum. 
Fibroblasts are a group or family of cells, which are present in virtually all 
tissues and arise from all three germ layers. Fibroblasts function in the deposition, 
maintenance, degradation and remodulation of the ECM. Fibroblasts have also 
generally been regarded as target cells of cytokines and growth factors. Hence, the 
use of any prospective biomaterial necessitates the need for knowledge of its 
interaction with fibroblasts (Radhika et al., 1999). Fibroblasts cultured in collagen 
gels have been reported to express a physiological behavior comparable to that 
exhibited in vivo.  Fibroblasts become the predominant cells by the end of the first 
week of healing. They originate from nearby connective tissue cells. The stimulus for 
subsequent fibroblasts proliferation and collagen synthesis are induced by growth 
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factors. The fibroblasts migrate into the wound forming adhesive contact with the 
fibrin strands from the initial wound clot and with collagen fibers and fibronectin. 
The fibroblasts activity depends on the adequacy of the local oxygen supply. The 
fibroblasts proliferate and migrate along the fibronectin, crossing the wound and 
establishing a lattice for collagen synthesis (Porras, Reyes and Mustoe, 1994). 
 
1.2.2 Correlation between Keratinocytes and Fibroblasts 
 
 
The biological mechanisms for the normal healing process toward an 
excessive reparative response are largely unidentified. Obviously, the most visible 
feature of the hypertrophic scar (HSc) is the excessive deposition of collagen, 
suggesting that the equilibrium of collagen synthesis and degradation is out of 
control. The cell predominantly present in HSc is the fibroblasts, the cell that is 
playing an important role in collagen synthesis (Gu et al., 2005 and Nedelec et al., 
2000). 
Excessive biosynthesis of extracellular matrix proteins (ECM) by fibroblasts 
has been suggested as one of the potential contributing factors leading to the 
accumulation of excessive matrix. Comparatively, hypertrophic scar fibroblasts 
showed a higher collagen type-I and type-III mRNA expression and produced 
additional collagen than normal skin fibroblasts (Zhang et al., 1995). Excessive 
matrix accumulation may occur in the case of increased synthesis of extracellular 
matrix proteins or declined in the matrix degradation. Reduced collagenase activity 
of HSc fibroblasts may be responsible for excessive accumulation of collagen, 
possibly due to activity of collagenase inhibitors such as α2-macroglobulin which 
was found in the extracellular matrix of HSc (Ghahary et al., 1996). According to 
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Sawicki et al., 2005, epidermal growth factors may play a vital role in the process of 
hypertrophic scarring under specific conditions as occurring during delayed wound 
healing. This is supported by observation that able to control proliferation of 
fibroblasts to synthesize growth factors, which in turn will stimulate keratinocyte 
proliferation (Werner et al., 2007), fibroblasts collagen synthesis and collagenase 
activity (Garner, 1998). 
 
1.2.3 Wound Healing 
 
Wound healing is a well-ordered and highly coordinated process involving 
inflammation, cell proliferation, matrix deposition, and tissue remodeling (Figure 2). 
After injury, the formation of new tissues begins with re-epithelialization and 
followed by the granulation of tissue formation. The latter process encompasses the 
accumulation of macrophage, in growth of fibroblast, formation of matrix and also 
angiogenesis (Clark, 1996). 
Throughout the inflammatory phase, blood clots form in wound and loosely 
unite the wound boundaries. This deep wound healing phase involved the 
inflammation; a vascular and cellular reaction that facilitate to eliminate microbes, 
foreign materials and dying tissues in preparation for repair process. The 
vasoconstriction followed by active vasodilatation increased permeability of blood 
vessels enhanced the deliverance of helpful cells (Broughton and Rohrich, 2005). 
These include the phagocytic white blood cells called neutrophils, monocytes (which 
develop into macrophages that phagocytize microbes) and mesenchymal cells (which 
develop into fibroblasts). In the migratory phase, the clots become scab, and 
epithelial cells migrate beneath the scab to bridge the wound.  
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Figure 2: The phase of cutaneous wound repair. Adapted from Clark, (1996). The 
molecular and cellular biology of wound repair.  
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In the granulation tissue phase, fibroblasts migrate along fibrin threads and 
start to synthesize scar tissue and damaged blood vessels begin to regrow. This is 
followed by the proliferative phase which is recognized by the extensive growth of 
epithelial cells beneath the scab, deposition of collagen fibers in random pattern by 
fibroblasts, and continued growth of blood vessels. Finally, in the maturation phase 
in which the scab sloughs off once the epidermis has been reinstate to normal 
thickeness. Collagen fibers will be more organized, fibroblasts decreased in number 
and blood vessel are restored to normal (Tortora and Grabowski, 2004). 
Successful wound healing is the result of a complex interaction between 
stimulatory and regulatory cytokine, growth factors, the fibroblast, epithelial cells 
and endothelial cells that populate the wound. The purpose of wound healing is to 
restore the functions of skin, such as protection of the body against harmful 
environmental entities, prevention of entry of microorganisms and loss of plasma, the 
regulation of body temperature, the processing and interpretation of environmental 
information through the neurosensory system and social-interactive function 
(William and Phillips, 1996). 
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1.2.4 Hypertrophic scar and Keloid 
 
The ability to heal wounds by scar tissue formation is essential for the 
survival of human. A preferred scar is one that matures rapidly without contracture 
or increase in width and without forming more collagen than necessary for its 
strength. However, in most instances particularly following burn injury, scarring 
becomes a real concern and a clinical challenge in the treatment of patients. The 
scars are itchy, painful, and unsightly and interfere with function and daily activities. 
These are the most common reasons for patients requesting plastic and reconstructive 
surgery. The effective treatment and prevention remain elusive.  
Both HSc and keloids resulted from an exaggerated and perpetuated fibrotic 
phase of the wound healing response (Uitto, 1991). HSc and keloids are the type of 
scarring which can be characterized by the excessive collagen synthesis and 
deposition of fibroblasts produced during the wound healing process, particularly 
after severe thermal injury (Castagnoli et al., 1997).  However, the exact mechanism 
involved in the scarring remains unclear. HSc is common; they are wide, often red, 
itchy and even painful. HSc is a tumor-like lesion which is elevated above the level 
of surrounding skin. The edges are usually prominent and end abruptly. They are 
typically raised scars that remain within the boundaries of the original wound and 
frequently raised spontaneously after the initial injury (Bayat et al., 2003) (Figure 3 
a).  
Ultrastructurally keloids are more disorganized than HSc. In contrast to HSc, 
keloids extend beyond the original wound margin and invade the surrounding normal 
skin in a way that is site specific (Mafong and Ashinoff, 2000). A keloid continues to 
grow over time, does not regress spontaneously, and almost invariably recurs after  
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(b) 
 
Figure 3: The appearance of HSc and keloid from patients of this study before 
surgery. (a) HSc (b) keloid. Both scars resulted from delayed wound healing. Keloid 
has a more prominent features compared to HSc.  
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simple excision. Keloids are characterized as collagenous, cutaneous lesions and do 
not regress spontaneously. Keloids are wide, raised and deep scars with excessive 
fibrous tissue that resulted from skin injury (Figure3b). Keloid formation is 
characterized by an extended period of fibroblasts proliferation and elevated rate of 
collagen synthesis with a decreased rate of collagen degradation (Orimolade et al., 
2011).  
The increased metabolic activity of HSc and keloids is reflected in the 
elevated glycolytic enzyme activity, the fibronectin deposition and the collagen 
mRNA expression. Fibroplasia in these abnormal scars continues beyond the third 
week of post injury. The scars remain immature, with an abnormally high content of 
type-III collagen and a disorganized pattern of collagen deposition.  
 
An array of treatments modalities has been introduced to manage HSc and 
keloid (Su et al., 1998 ; Mustoe et al., 2002). Alster et al. (1997) and Niessen et al. 
(1999) presented comprehensive reviews on the nature and treatment modalities of 
hypertrophic scar and keloids. An international panel of clinicians recently reviewed 
the available literature for an evidence based analysis of the treatment for cutaneous 
scarring and recommended useful approaches for the clinicians where evidence was 
lacking (Mustoe et al., 2002). At present, accepted modalities for the prevention of 
hypertrophic scarring include silicone occlusive therapy (Cruz-Korchin, 1996; Ahn 
et al., 1991; Lyle et al., 2001), steroid injections (Tang, 1992) and pressure garments 
(Linares et al., 1993). Pressure garment is a widely used therapy where the patients 
need to continuously wear the elastic compression of garments for months. Under 
pressure, collagen fibers in the dermis will modify the disorganized orientation and 
will adopt a more parallel arrangement which is the characteristic of normotrophic 
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healing. The scar becomes less vascular, expresses less glycosamnioglycans and has 
less collagen deposition (Akkermans, 1999). Therefore in the treatment with pressure 
garments, it is believed that pressure controls collagen synthesis to the levels as in 
the normal scar tissue. 
 
1.2.5 Primary cell culture 
 
Tissue culture was first devised at the beginning of this century as a useful 
method for studying the behavior of animal cells in free systemic variation that might 
arise in the animal during normal homeostasis and under the stress of an experiment 
(Cruz et al., 2009). As the name implies, the technique is elaborated first with 
undisaggregated fragments of tissue and growth was restricted to the migration of 
cells from tissue fragments, with occasional mitoses in the outgrowth. Since 
culturing cells from primary tissues conquered the field for more than 50 years, it is 
not surprising that the name ‘tissue culture’ has remained in spite of the fact that the 
most explosive expansion in this area in the second half of the 20
th
 century utilized 
cell culture (Freshney, 2010).  
 Cell culture refers to a culture derived from dispersed cells taken from 
original tissue of a primary culture or from an established cell line or cell strain by 
enzymatic, mechanical or chemical desegregation. According to Sultan and 
Haagsman (2001), uniqueness of primary cell cultures is the possibility to amend the 
metabolic and regulatory pathways of cells of interest and to delineate the 
pysiological effects of various compounds and drugs in a controlled way. The 
refinement of this experimental tool can be expected to accelerate species-specific 
research. Cells isolation of several cell types from the same tissue biopsies would 
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constitute a significant advantage in the identification of the cells that responsible for 
dysfunction in skin diseases (Abdel Naseer et al., 2005).  
 
    1.2.5.1 Keratinocytes cultures 
 
 Before 1974, there had been many attempts to cultivate human epidermal 
cells in culture. The growth obtained was very limited and inadequate to permit 
satisfactory subcultivation (Green, 2004). Essentially no basic or applied work could 
be done on co-culture of human keratinocytes with other variety of cells. Rheinwald 
(1974) had started his culture work on mouse teratoma, a germ line tumor growing as 
a transplanted tumor to differentiate into a number of somatic tissues. When he put 
cells disaggregated from a tumor into a culture, colonies of different appearance 
arose including an unusual-looking epithelial cell type together with a background of 
teratomal fibroblasts. Once lethally irradiated 3T3 cells had been introduced, the 
epithelial cells grew rapidly in culture system. The 3T3 cells thus had been widely 
applied in supporting the growth of the epithelial cells in a culture. This made it 
possible to isolate clones of the epithelial cells and study their behavior. It became 
obvious that some of these clones were keratinocytes, the principal cell type of all 
stratified squamous in epidermis (Rheinwald and Green, 1975). With the subsequent 
improvements in cultivation, keratinocytes became the most cultivable of human 
diploid cell types (Barrandon and Green, 1987). The ability to culture human 
keratinocytes is a great importance to the clinician and the research workers.  
According to some studies, human keratinocytes cultures become important 
studies of keratins and their numerous disease-producing mutations (Cooper et al., 
1985; Moll et al., 1982; Wu et al., 1982). Furthermore, the cross-linked envelopes of 
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terminal differentiation can also be studied. Recent improvements and simplification 
of the method of preparing the cultures for grafting are likely to expand the use of 
cultured autologous keratinocytes in the treatment of wound (Pellegrini, 1999 and 
Ronfard et al., 2000). 
 
 1.2.5.2 Fibroblasts cultures 
 
 The nutritional constitution of the medium, the presence of inducer or 
repressor substances and the interaction of cells with the substract control the 
expression of specialized functions in a culture. Most of the cell lines grow well at 
pH 7.4. Although the optimum pH for cell growth varies relatively among different 
cells strain, some normal fibroblast cell lines performed best at pH 7.4 to 7.7, and 
transformed cells may do better at pH 7.0 to 7.4 (Freshney, 2000). Fibroblasts can 
give rise to other cells, such as bone cells, fat cell, and smooth muscle cells. All of 
these cells are of mesodermal origin. The fact that fibroblasts can easily proliferate 
makes them a popular cell type for cell cultures in biological research. Notably, 
mouse embryonic fibroblasts (MEFs) are often used as "feeder cells" in human 
embryonic stem cell research (Reubinoff et al., 2000; Ludwig et al., 2006). However, 
many researchers are gradually phasing out MEF's in favor of culture media with 
precise defined ingredients of exclusive human derivation. 
 Skin cultures of fibroblasts and keratinocytes are also available for 
cytotoxicity and inflammation research such as Episkin™ (Saduc) and Epiderm™ 
(Mat Tek) and from Advanced Tissue Sciences. These products are prepared by 
combining keratinocytes with dermal fibroblasts and supported with a nylon collagen 
net called “skin equivalent” (Freshney, 2000). 
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 The ability of fibroblasts in the granulation tissue to differentiate into 
myofibroblasts is not only seen as the start of wound contraction but is also the cause 
of scar formation, contractures and hypertrophy. In culture, myofibroblasts are 
characterized by slower growth rates, presence of stress fibers and larger stellate cell 
morphology. In comparison, fibroblasts have higher growth rate and spindle shape 
morphology with predominant fillamentous actin (Lamme, 1999). 
 
1.2.5.3 Scar keratinocytes and fibroblasts culture 
 
 Dermal fibroblasts play a major role in scar formation and have been used in 
vitro for a variety of wound repair studies to uncover the mechanism of fibrosis. 
Often, in vitro fibroblasts exhibit characteristic typical of their in vivo phenotypes. 
For instance keloid fibroblasts continue to produce high levels of collagen, 
fibronectin, elastin, and proteoglycan in vitro and show aberrant responses, compared 
with normal fibroblasts, to metabolic modulators such as glucocorticoids, 
hydrocortisone, growth factors and phorbol esters (Tuan et al., 1991). The altered 
response of keloid fibroblasts to these metabolic modulators are thought to attribute 
to the pathogenesis of keloid formation. Fibroblasts from hypertrophic scars also 
display a moderate elevation in collagen production in vitro. However, their 
responses to the metabolic modulators are similar to normal fibroblasts (Russell et 
al., 1995).  
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1.2.6 Immunocharacterization of keratinocytes and fibroblasts 
 
Detection of antigens in cultured cells is generally referred to as 
immunocytochemistry. Immunocytochemistry is the demonstration of a cellular 
constituent in situ by detecting specific antibody-antigen interactions where the 
antibody has been tagged with a visible label. The visual marker may be a 
fluorescent dye, colloidal metal, hapten, radioactive marker or an enzyme. 
Considerable attention has been focused on cell markers development for cells 
detection especially cell specialized from stem cells. Despite the diversity of 
techniques now available to the researcher, ideally, maximal signal strength along 
with minimal background or non-specific staining are required to give optimal 
antigen demonstration. Central to these techniques is the use of an antibody to link a 
cellular antigen specifically to a stain that can be readily visualized with a 
microscope. A commonly used technique is immunocytochemical analysis of a cell 
with their specific markers or antigen. The keratinocytes are the major cell found in 
skin epidermal while fibroblasts in dermal. Cytokeratin 6 (CK6), involucrin, heat 
shock protein 47 (HSP 47) and fibroblasts surface protein (FSP) are among the 
markers to be used to identify cells from human skin epidermal and dermal (Strutz et 
al., 1995) 
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1.2.7 Nitric Oxide (NO) 
 
 
Nitric Oxide (NO, formula N=O) is a simple, inorganic gaseous free radical 
whose predominant functions are that of a messenger and effectors molecule. In 
mammals, NO is synthesized by a family of enzymes referred to as the nitric oxide 
synthase (NOS). NO originally identified as endothelium-derived relaxing factor, cell 
types such as macrophages, endothelial cells, neurons, hepatocytes, fibroblasts, 
epithelial cells, keratinocytes, smooth muscle cells, cardiac myocytes and many more 
have been shown to produce NO (Geller and Billiar, 1998).  
Nitric Oxide also has been revealed to possess several physiologic and 
pathophysiologic activities. These include smooth muscle relaxation or vasolidation, 
anti-microbial activities, immune regulation, anti-proliferation and 
neurotransmission. The biosynthesis of NO is mediated by NO synthases (NOS), 
beta-nicotinamide adenine dinucleotide phosphate (reduced form)-dependent 
enzymes that catalyze the oxidation of one of the guanidine nitrogen atoms of L-
arginine with molecular oxygen to form NO and L- citrulline (Geller and Billiar, 
1998).  NO synthesis is catalyzed by one of three isoforms of NOS: NOS I (neuronal 
or nNOS), NOS III (endothelial eNOS) and NOS II (inducible or iNOS).  Expression 
of both the constitutive as well as the inducible isoform has been shown in several 
cells resident, including keratinocytes and fibroblasts. NO also enhanced the 
production of collagen type 1 by normal fibroblast at the post-translational level in 
vitro study (Witte et al., 2000). The inhibition of NOS by competitive inhibitors has 
been shown to reduce collagen synthesis (Schaffer et al., 1997). 
 
 
 22 
1.2.8 Inducible nitric oxide (iNOS) 
 
iNOS is one of three key enzymes generating NO from the amino acid L-
arginine. iNOS-derived NO plays an important role in numerous physiological and 
pathophysiological conditions for example to mediate vasolidation, angiogenesis, 
inflammation re-epithelization, collagen deposition and various immune responses. 
Three isoforms of NOS have been distinguished by cloning their genomic and 
complementary DNA in several mammalian species including human. Activities of 
two of these isoforms are dependent on elevated intracellular Ca
2+
 and exogenous 
calmodulin and are constitutively expressed (cNOS). cNOS appears to be restricted 
to endothelial cells, while another is expressed in neurons (cNOS) of the central and 
peripheral nervous system and in skeletal muscles. The third isoforms, iNOS is 
independent of elevated intracellular Ca
2+
 and possess its own calmodulin as a tightly 
bound subunit. This isoform is not expressed under normal conditions but can be 
induced in many cell types by inflammatory cytokines and bacterial 
lipopolysaccharide (LPS) (Wang et al., 1996).  
Expression of the inducible isoform has been shown in several cell residents 
in the skin, including keratinocytes and fibroblasts. In humans, as in other mammals, 
many types of cells have been shown to synthesize NO and express NOS. Under 
normal conditions, fibroblasts are responsible for tissue integrity and extracellular 
matrix metabolism by producing structural (e.g., collagens) and functional (e.g., 
collagenase) proteins. In damaged tissues, activated fibroblasts migrate towards the 
wound site, proliferate and produce more extracellular matrix proteins, express NOS 
and synthesize NO, suggesting that they may participate in regulating the 
inflammatory, healing process of wound and scar tissue remodeling (Wang et al., 
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1996). Jorens et al., 1992 also reveals that iNOS plays important role in wound 
healing through its vasodilatation and anti-proliferative effect. 
 
1.2.9 Vitamin E 
 
Vitamin E was discovered in 1922 in green leafy vegetables by University of 
California researchers, Herbert Evans and Katherine Bishop. In 1936, it was 
discovered that vitamin E was abundant in wheat germ oil. Two years later, it was 
chemically synthesized for the first time. Vitamin E then emerged as an essential, fat 
soluble nutrient that functions as an antioxidant in the human body. Vitamin E is an 
essential component of the human diet and is synthesized exclusively by 
photosynthetic organisms. It is essential because human body cannot produce its own 
Vitamin E. Vitamin E represents a generic term of two groups of chemically related, 
lipid-soluble molecules that collectively known as tocochromanols; the tocopherols 
and tocotrienols (Falk and Munne Bosch, 2010). It consists of eight naturally 
occurring isomers, a family of four tocopherols (α, β, γ and δ) and four tocotrienols 
(α, β, γ and δ homologues (Packer et al. 2001). 
A double blind and randomized trial assessing the influence of topical 
Vitamin E or steroid on scar formation in burn patient reported by Jenkins et al., 
1986, did not demonstrate any beneficial effect of either on scar thickness, range of 
motion or ultimate cosmetic appearance. Therefore, the benefits of vitamin E on 
surgical wound healing specifically scar formation have not been reliably 
demonstrated. However, a study by Gray (2003) discovered that Vitamin E may help 
to minimize the damage and potential healing of wounds from source of radiation. 
According to Mckay and Miller (2003), vitamin E may have alternative effects on 
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different types of wounds with the presence of other nutrients. the combined action 
Limited scope of the study regarding the effect of Vitamin E on the prevention and 
treatment of scars leads to a lot of unanswered questions. 
 
1.2.10 Tocotrienols (T3s) and Palm oil 
 
 T3s is one of the two sub groups of molecules belonging to Vitamin E family 
derived from locally produced palm oil. T3s are found in high concentrations (800-
1500ppm) in crude palm oil extracted from the fruit of Elaeis guineensis. T3s are the 
primary form of Vitamin E in the seed endosperm of most monocotyledone including 
a few important cereal grains such as wheat, rice and barley (Sen et al., 2005).  T3s 
differ structurally from tocopherols by the presence of the unsaturated and isoprenoid 
chain possessing three double bonds (Figure 4). Interestingly, besides having strong 
antioxidant activity, it also has other characteristics such as a hypocholesterolemic, 
anti-atherogenic, antithrombic, anticarcinogenic and immunomodulatory actions 
(Qureshi et al., 2002; Khanna et al., 2005b; Unchern et al., 2003). T3s has been 
found to have a better antioxidant properties compared to α-tocopherol (Osakada et 
al., 2004; Mazlan et al., 2006). According to Saito et al., 2004, T3s posses a higher 
antioxidant activity compared to α-tocopherol due to its uniform distribution in the 
membrane lipid bilayer. The unsaturated side chain of T3s allows for more efficient 
penetration into tissue that have saturated fatty layers such as brain and liver (Suzuki 
et al., 1993). T3s showed improved absorption ability through the skin and 
incorporate into cell membrane for the prevention of oxidative damaga when applied 
topically (Yoshida et al., 2003). 
 
